LMP7 polymorphism may modify the presentation and clinical impact of minor histocompatibility antigens in matched related hematopoietic stem cell transplantation

Cell Immunol. 2021 Jun:364:104329. doi: 10.1016/j.cellimm.2021.104329. Epub 2021 Mar 9.

Abstract

Differential expression of minor histocompatibility antigens between the recipient and donor determines their disparity and can be modified by immunoproteasomes that regulate their processing and presentation. We examined the impact of HA-1 and HA-8 disparity, and immunoproteasome LMP7 polymorphism in 130 pairs. In multivariate analysis, HA-1 disparity showed a statistically significant association with an increased incidence of acute graft-versus-host disease (aGVHD) II-IV (p = 0.043, HR: 3.71, 95%CI = 1.04-13.26), while LMP7-Q/Q showed a trend toward increased incidence of aGVHD compared to LMP7-Q/K and K/K genotypes (p = 0.087, HR: 2.36, 95%CI = 0.88-6.31). All HA-1 and HA-8 disparate patients who developed aGVHD had the LMP7-Q/Q genotype. No significant association could be detected between HA-1, HA-8, or LMP7 and chronic GVHD, relapse-free survival (RFS), overall survival (OS), or transplant-related mortality (TRM). In conclusion, we suggested an association between the HA-1 disparity and the risk of developing aGVHD with a possible modifying effect of LMP7.

Keywords: Acute-graft-versus host disease; HA-1; HA-8; Hematopoeitic stem cell transplantation; Immunoproteasome; LMP7; Minor histocompatibility antigen.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Antigen Presentation
  • Child
  • Child, Preschool
  • Female
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype*
  • Graft vs Host Disease / epidemiology
  • Graft vs Host Disease / genetics*
  • Graft vs Host Disease / mortality
  • Hematopoietic Stem Cell Transplantation*
  • Histocompatibility
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Minor Histocompatibility Antigens / immunology*
  • Oligopeptides / immunology*
  • Polymorphism, Genetic
  • Proteasome Endopeptidase Complex / genetics
  • Proteasome Endopeptidase Complex / metabolism*
  • Survival Analysis
  • Young Adult

Substances

  • HA-1 antigen
  • Minor Histocompatibility Antigens
  • Oligopeptides
  • PUM3 protein, human
  • LMP7 protein
  • Proteasome Endopeptidase Complex